| Dr Michael A Jozefczyk, MD | |
|
600 E Genesee St, Suite 305, Syracuse, NY 13202-3108 | |
| (315) 234-3300 | |
| Not Available |
| Full Name | Dr Michael A Jozefczyk |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 600 E Genesee St, Syracuse, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043321607 | NPI | - | NPPES |
| 02440884 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 157290 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael A Jozefczyk, MD 600 E Genesee St, Suite 305, Syracuse, NY 13202-3108 Ph: (315) 234-3300 | Dr Michael A Jozefczyk, MD 600 E Genesee St, Suite 305, Syracuse, NY 13202-3108 Ph: (315) 234-3300 |
News Archive
DocuSign, Inc. (DocuSign®) and USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, today announced a new partnership to help organizations automate regulated business processes for dramatic ROI, increased security and compliance, and faster speed to market.
Catasys, Inc., a provider of proprietary big data based analytics and predictive modeling driven behavioral health management services for health plans, announced today that it has begun enrolling members in its OnTrak Program with Health Alliance Medical Plans (Health Alliance) in Illinois. In April, Catasys and Health Alliance announced a multi-year agreement for the OnTrak Program.
The drug rituximab causes considerable kidney injury healing in patients with membranous nephropathy, a common form of kidney disease, according to a study appearing in the November 2008 issue of the Clinical Journal of the American Society Nephrology (CJASN).
Amazon Filters reports a leading pharmaceutical company is using SupaPore PPG pleated depth filter cartridges to enable them to achieve a safe, enclosed point-of-use filter on their nitrogen gas distribution line used in the production of an Active Pharmaceutical Ingredient (API) for kidney dialysis treatments.
Patients with Duchenne muscular dystrophy have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.
› Verified 9 days ago
Dr. Diana A Dimitrov, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1226 E Water St, Syracuse, NY 13210 Phone: 315-478-4185 | |
Dr. Matthew Brian Elkins, M.D., PH.D Pathology Medicare: Accepting Medicare Assignments Practice Location: 750 E. Adams Street, Syracuse, NY 13210 Phone: 315-464-6751 Fax: 315-464-6749 | |
Dr. Christian N Ezidiegwu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 Ostrom Ave, Syracuse, NY 13210 Phone: 315-447-7041 | |
Dr. Robert John Corona Jr., DO, CPE Pathology Medicare: Medicare Enrolled Practice Location: 750 E. Adams Street, Syracuse, NY 13210 Phone: 315-464-6751 Fax: 315-464-6749 | |
Lazaro Rosales, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-6751 Fax: 315-464-6749 | |
Diandra Perez, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-7117 |